Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
SZSE:301130.SZ
28.32 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 52.219 | 63.824 | 63.612 | 60.861 | 65.195 | 53.607 | 56.409 | 58.647 | 55.44 | 71.254 | 67.589 | 63.519 | 53.106 | 78.868 | 70.685 | 73.876 | 62.227 | 82.659 | 81.241 | 75.17 | 47.248 |
| Cost of Revenue
| 12.302 | 17.525 | 14.806 | 16.197 | 14.644 | 15.674 | 10.793 | 9.728 | 10.541 | 14.784 | 12.03 | 11.28 | 9.324 | 12.914 | 11.957 | 11.903 | 9.929 | 12.743 | 12.093 | 11.114 | 7.961 |
| Gross Profit
| 39.917 | 46.299 | 48.806 | 44.664 | 50.551 | 37.933 | 45.616 | 48.919 | 44.899 | 56.47 | 55.559 | 52.238 | 43.783 | 65.954 | 58.728 | 61.974 | 52.298 | 69.916 | 69.148 | 64.056 | 39.288 |
| Gross Profit Ratio
| 0.764 | 0.725 | 0.767 | 0.734 | 0.775 | 0.708 | 0.809 | 0.834 | 0.81 | 0.793 | 0.822 | 0.822 | 0.824 | 0.836 | 0.831 | 0.839 | 0.84 | 0.846 | 0.851 | 0.852 | 0.832 |
| Reseach & Development Expenses
| 2.646 | 0.199 | 2.916 | 2.957 | 4.153 | 3.473 | 2.168 | 1.565 | 1.494 | 7.646 | 1.201 | 1.279 | 1.617 | 3.184 | 2.273 | 3.928 | 4.531 | 1.319 | 1.126 | 0.96 | 0.96 |
| General & Administrative Expenses
| 8.861 | -12.728 | 17.207 | -1.71 | 5.955 | -8.782 | 12.879 | -2.451 | 6.178 | 4.243 | 12.528 | -2.211 | 5.467 | 1.486 | 7.659 | 3.771 | 3.771 | -50.461 | 11.3 | 4.001 | 4.001 |
| Selling & Marketing Expenses
| 19.808 | 25.209 | 32.574 | 26.829 | 28.662 | 29.546 | 28.799 | 32.083 | 29.399 | 36.438 | 36.54 | 33.143 | 27.514 | 42.296 | 38.736 | 35.961 | 35.961 | 44.155 | 48.77 | 35.801 | 35.801 |
| SG&A
| 28.67 | 12.481 | 49.781 | 32.156 | 35.324 | 33.007 | 41.678 | 29.633 | 35.577 | 40.505 | 49.068 | 30.931 | 32.981 | 43.783 | 46.395 | 39.755 | 36.196 | -6.306 | 60.07 | 39.503 | 39.503 |
| Other Expenses
| -0.261 | 26.959 | -14.997 | -0.389 | -0.071 | -0.073 | -0.028 | -0.118 | -0.001 | -4.197 | -0.001 | -0.021 | -1.006 | -0.026 | 1.071 | -47.236 | -40.321 | -5.733 | 0 | -47.816 | -30.743 |
| Operating Expenses
| 31.055 | 39.639 | 37.7 | 35.502 | 39.548 | 36.553 | 37 | 28.644 | 37.731 | 43.954 | 44.955 | 38.652 | 35.387 | 46.591 | 46.419 | -47.236 | -40.321 | 47.759 | 55.486 | -47.816 | -30.743 |
| Operating Income
| 8.862 | 6.661 | 11.106 | 9.162 | 11.003 | 1.38 | 12.552 | 24.366 | 11.043 | 12.516 | 13.819 | 15.61 | 10.184 | 19.929 | 13.026 | 14.738 | 11.977 | 19.88 | 14.579 | 16.24 | 8.544 |
| Operating Income Ratio
| 0.17 | 0.104 | 0.175 | 0.151 | 0.169 | 0.026 | 0.223 | 0.415 | 0.199 | 0.176 | 0.204 | 0.246 | 0.192 | 0.253 | 0.184 | 0.199 | 0.192 | 0.241 | 0.179 | 0.216 | 0.181 |
| Total Other Income Expenses Net
| 0 | 0.885 | -0 | -0.501 | -0.203 | 2.809 | 2.403 | -0.118 | -0.001 | -0.67 | -0.001 | -0.021 | -1.006 | -0.026 | -0.136 | -1.531 | -0 | -0.068 | 0 | -0.048 | -0.2 |
| Income Before Tax
| 8.862 | 7.545 | 11.106 | 11.761 | 16.102 | 10.499 | 12.524 | 24.247 | 11.042 | 11.845 | 13.818 | 15.589 | 9.179 | 19.903 | 12.889 | 14.438 | 11.977 | 19.812 | 14.579 | 16.192 | 8.344 |
| Income Before Tax Ratio
| 0.17 | 0.118 | 0.175 | 0.193 | 0.247 | 0.196 | 0.222 | 0.413 | 0.199 | 0.166 | 0.204 | 0.245 | 0.173 | 0.252 | 0.182 | 0.195 | 0.192 | 0.24 | 0.179 | 0.215 | 0.177 |
| Income Tax Expense
| 1.21 | 1.343 | 1.491 | 1.353 | 2.059 | 1.291 | 1.553 | 3.499 | 1.466 | 3.242 | 2.434 | 2.759 | 1.273 | 2.036 | 1.82 | 1.927 | 1.404 | 3.273 | 2.21 | 2.434 | 1.268 |
| Net Income
| 8.294 | 6.202 | 9.615 | 10.409 | 14.043 | 9.208 | 10.971 | 20.748 | 9.575 | 8.603 | 11.384 | 12.83 | 7.906 | 17.867 | 11.07 | 12.51 | 10.572 | 16.539 | 12.369 | 13.758 | 7.077 |
| Net Income Ratio
| 0.159 | 0.097 | 0.151 | 0.171 | 0.215 | 0.172 | 0.194 | 0.354 | 0.173 | 0.121 | 0.168 | 0.202 | 0.149 | 0.227 | 0.157 | 0.169 | 0.17 | 0.2 | 0.152 | 0.183 | 0.15 |
| EPS
| 0.11 | 0.08 | 0.13 | 0.14 | 0.17 | 0.11 | 0.14 | 0.26 | 0.12 | 0.11 | 0.14 | 0.16 | 0.12 | 0.22 | 0.14 | 0.19 | 0.17 | 0.2 | 0.24 | 0.17 | 0.12 |
| EPS Diluted
| 0.11 | 0.08 | 0.13 | 0.14 | 0.17 | 0.11 | 0.14 | 0.26 | 0.12 | 0.11 | 0.14 | 0.16 | 0.12 | 0.22 | 0.14 | 0.19 | 0.17 | 0.2 | 0.24 | 0.17 | 0.12 |
| EBITDA
| 8.997 | 7.558 | 11.122 | 17.962 | 16.124 | 15.231 | 17.209 | 28.861 | 15.655 | 10.997 | 18.453 | 20.159 | 13.748 | 24.013 | 17.066 | 19.151 | 16.69 | 24.933 | 18.767 | -16.458 | 39.288 |
| EBITDA Ratio
| 0.172 | 0.118 | 0.175 | 0.295 | 0.247 | 0.284 | 0.305 | 0.492 | 0.282 | 0.154 | 0.273 | 0.317 | 0.259 | 0.304 | 0.241 | 0.259 | 0.268 | 0.302 | 0.231 | -0.219 | 0.832 |